Related Experiment Video
Updated: Nov 7, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Systematic Identification of Familial Hypercholesterolaemia in Primary Care-A Systematic Review
Luisa Silva1, Nadeem Qureshi1, Hasidah Abdul-Hamid1,2
1Primary Care Stratified Medicine (PRISM) Group, NIHR School of Primary Care Research, University of Nottingham, Nottingham NG7 2RD, UK.
Insights
Systematic identification of familial hypercholesterolaemia (FH) in primary care shows limited effectiveness. On-screen prompts in electronic health records offer a small increase in identifying definite FH, but more research is needed.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Public Health
Background:
- Familial hypercholesterolaemia (FH) is an inherited condition leading to premature cardiovascular disease.
- The majority of FH patients remain undiagnosed, highlighting a critical gap in detection.
- Effective strategies for systematic FH identification in primary care are needed.
Purpose of the Study:
- To systematically review interventions for identifying FH in primary care settings.
- To assess the effectiveness of different methods for FH case finding.
- To evaluate strategies for improving the diagnosis of FH in non-specialist healthcare environments.
Main Methods:
- Systematic review of intervention studies for FH identification in primary care.
- Inclusion of three non-randomized intervention studies.
- Analysis of interventions including electronic health record prompts, laboratory result comments, postal invitations, and outreach nurse assessments.
Main Results:
- On-screen prompts in electronic health records were used in all included studies for systematic FH identification.
- No significant increase in definite FH identification was observed with prompts combined with postal invitations (Simon-Broome criteria), though possible FH identification increased by 25.4%.
- On-screen prompts alone showed a small increase in definite FH identification (0.05%), but combining them with an outreach nurse did not yield significant improvements.
Conclusions:
- There is insufficient evidence to determine the most effective method for systematically identifying FH in primary care.
- On-screen prompts show potential but require further investigation regarding their optimal implementation and impact.
- Adverse effects were not reported in the included studies, suggesting interventions are likely safe.
Abstract:
Familial hypercholesterolaemia (FH) is a common inherited cause of premature cardiovascular disease, but the majority of patients remain undiagnosed. The aim of this systematic review was to assess the effectiveness of interventions to systematically identify FH in primary care. No randomised, controlled studies were identified; however, three non-randomised intervention studies were eligible for inclusion. All three studies systematically identified FH using reminders (on-screen prompts) in electronic health records. There was insufficient evidence that providing comments on laboratory test results increased the identification of FH using the Dutch Lipid Clinic Network (DLCN) criteria. Similarly, using prompts combined with postal invitation demonstrated no significant increase in definite FH identification using Simon-Broome (SB) criteria; however, the identification of possible FH increased by 25.4% (CI 17.75 to 33.97%). Using on-screen prompts alone demonstrated a small increase of 0.05% (95% CI 0.03 to 0.07%) in identifying definite FH using SB criteria; however, when the intervention was combined with an outreach FH nurse assessment, the result was no significant increase in FH identification using a combination of SB and DLCN criteria. None of the included studies reported adverse effects associated with the interventions. Currently, there is insufficient evidence to determine which is the most effective method of systematically identifying FH in non-specialist settings.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...

